Mediclinic International (LON:MDC) Earns “Hold” Rating from Berenberg Bank

Berenberg Bank reaffirmed their hold rating on shares of Mediclinic International (LON:MDC – Get Rating) in a research note issued to investors on Tuesday, MarketBeat.com reports. Berenberg Bank currently has a GBX 464 ($5.68) target price on the stock.

Separately, Barclays raised their price objective on Mediclinic International from GBX 385 ($4.72) to GBX 460 ($5.63) and gave the company an overweight rating in a research note on Tuesday, May 31st.

LON:MDC opened at GBX 445.80 ($5.46) on Tuesday. The stock has a market capitalization of £3.29 billion and a P/E ratio of 21.76. The stock has a 50-day moving average price of GBX 388.74 and a 200 day moving average price of GBX 351.21. The company has a current ratio of 1.79, a quick ratio of 1.67 and a debt-to-equity ratio of 79.76. Mediclinic International has a 12-month low of GBX 271.40 ($3.32) and a 12-month high of GBX 458.20 ($5.61).

The company also recently declared a dividend, which will be paid on Friday, August 26th. Shareholders of record on Thursday, August 4th will be given a dividend of GBX 3 ($0.04) per share. The ex-dividend date of this dividend is Thursday, August 4th. This represents a yield of 0.85%.

In related news, insider Tom Singer acquired 20,000 shares of the firm’s stock in a transaction dated Wednesday, May 25th. The stock was acquired at an average price of GBX 366 ($4.48) per share, with a total value of £73,200 ($89,661.93).

Mediclinic International Company Profile (Get Rating)

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates.

Read More